Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Here’s what’s next! We’ll see significant downward price movement near term on the order of 25% settling into range bound trading between 1.5/1.75 and 1.75/2 pennies as the chart sets up for the next leg down. .02 will prove to be strong resistance.
Single penny and change is printing.
Leo’s Lightsaber. If it’s effective against Beskar we’re onto something.
“what did they call the system before it was submitted on 9/7/22 with the "Device Name MANTA Laser"? “
How ‘bout the name change of the other thingy?
“Nobody spends somebody else's money as carefully as he spends his own. Nobody uses somebody else's resources as carefully as he uses his own. So if you want efficiency and effectiveness, if you want knowledge to be properly utilized, you have to do it through the means of private property." - Milton Friedman
Yet another bait and switch.
New investors, please join us in our misery as our CEO dilutes the bejesus out of us to fund a private company. You too could be part of this one man show! Step right up. Great ROI here just look at the chart!
Chart is horrid and will get much worse as it continues to push below a penny.
Leo’s thankful for the continued support!
New investors, please join us in our misery.
Newsflash, IPIX’s COVID rabbit hole failed and expedited shareholders to shares worth a penny. Time is up. IPIX is dead.
COVID is treated as the flu at this point by most of the world. The senate recently voted to remove the PED and the house will too. Dead too just like IPIX.
Does the most recent company filing and the declining share price count?
IPIX is dead.
Buy this stock if you like to watch your money disappear!
Next stop .01 and change.
Imminent.
How long before sub .02?
IPIX is dead. New investors, please join us in our misery!
Won’t be long before that link is dead too.
Yup. Boca Club poolside laughing his ass off.
Leo’s a snake. He knew there was a disagreement and chose those words to avoid saying it to investors upon the good doc’s departure imo. He skated around the statement by referencing OPPs. Operations with regard to the subject stated in filings filed after the good docs departure and after Bertolino‘s interview didn’t change. There was no conflict if you reference the filings against Leo’s statement. Operations were moving forward w/ phase 3. Insert Q and K filings and stock price into your timeline and the picture becomes clearer for me at least.
Operations have always been defined in the filings and they didn’t change in the 10Q following his departure.
The company’s OPPs could have nothing to do with the subject. How were the OPPS defined by the author at the time it was written?
“Given the timing, how reasonable is it to believe that "Dr. Jorgensen's resignation did not result from any disagreement with the Company"?
I don't think it's reasonable at all and I believe he left for one of two reasons, maybe both:
He felt that there were compelling reasons to go ahead with the B-ABSSSI Phase 3 and that it was being improperly "shelved".
He sensed that there was never a sincere intent to pursue B-ABSSSI to approval.”
The reality of the situation is IPIX is dead and shareholders are bagholders at a share price of 2 pennies and falling as the CEO‘a compensation remains unchanged. If it’s up to Leo, we’re all clearly screwed.
New shareholders, please grab a bag and join us in our misery.
Perhaps one day you will. For now, I don’t plan on elaborating.
”So they were the ONLY significant financial beneficiary of the "development" of Kevetrin.”
Yep. Nothing more than transfer of wealth.
Cronies dumping shares at the bid.
Brilacidin is next.
Follow the money…..
Item 8.01 Other Events.
In a personal dispute between Dr. Krishna Menon and a party named Aruda, Aruda claimed that although he had participated in the invention relating to the compounds and therapeutic uses disclosed and claimed in US Patent No. 8,338,454 ("454" Patent") he was inadvertently omitted as an inventor from "454 Patent" and applications related thereto. On August 28, 2014, a settlement took place between Dr. Menon and Aruda which resulted in the following: Menon acquired all of the rights Aruda claimed in the Kevetrin patents in return for (i) the transfer to Aruda and designees an aggregate of 16,000,000 shares of stock in Cellceutix over a period of 16 months, currently owned by the Menon Trust and (ii) and assigned a portion of the royalty revenues that may be payable to Menon, to Aruda and designees, as further detailed in the Agreement titled "Amendment to Menon-Cellceutix Agreement Without Changing the Total Royalties Payable Under the Terms of the Prior Agreement". Menon then transferred all Kevetrin patent rights to Cellceutix. The aforementioned share transfer was strictly between the personal holdings of Mr. Krishna Menon, the Menon Trust, and Aruda. No shares or royalty payments were issued by the Company.
https://seekingalpha.com/filing/1717409
Speaking of assets, liabilities, and movement of cash,… Where did Kevetrin disappear to?
That makes sense.
The ABSSSI trial is one of many reminders that a company is only as good as the company it keeps. IPIX is dead.
Yup. Dead.
Two turds swirling the same bowl. At least we’re conserving water at that point.
.01 and change.
Good point! I’ll add the chart to the board intro when I have time.